A blog about chemistry, drug development, science, and technology
Adeza has a new drug to help prevent premature births and is seen is a promising drug as reported by Forbes.
Adeza Shares Seen As Attractive Following FDA News - Forbes.com:
The article covers that the Reproductive Health Drugs Advisory Committee has recommended for approval Gestiva indicated to prevent premature births. Premature births occur much more frequently now than in past years mainly due to advancements made in fertility treatments; currently about 12% of all births are premature (less than 37 weeks gestation). Also, premature births tend to be very costly to the health care system. According to this site March of Dimes put the cost in 2003 of $11 billion for preterm birth.
Further Resources
• Press Release from Adeza on FDA recommendation for approval
• Adezas Gestiva recommended for FDA approval - Pharmaceutical Business Review
• FDA questions effectiveness of Gestiva at preventing preterm labor
Technorati Tags: Gestiva, premature birth, Adeza
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.110 seconds